Medical/Pharmaceuticals
TricValve® Transcatheter Bicaval Valves System Receives CE Mark
HONG KONG, May 20, 2021 /PRNewswire/ -- OrbusNeich® Medical Company Ltd. and P&F Products & Features®, under the joint partnership OrbusNeich P&F, today announced that the TricValve® Transcatheter Bicaval Valves System has received CE mark approval. The TricValve® Transcatheter Bicaval Valve (bi...
2021-05-20 17:00
1745
European Wellness and Dongci Join Forces To Bring Regenerative Medicine To Shandong, China
KOTA KINABALU, Malaysia, May 20, 2021 /PRNewswire/ -- European Wellness Biomedical Group has signed a memorandum of understanding (MOU) with Yantai Dongci ZhenAn Hospital Group to develop an exclusive multimillion dollar-project Regenerative Medicine Center inShandong, China. In a digital signin...
2021-05-20 16:54
2667
Regent Pacific's Deep Longevity Announces Partnership with LifeHub & LifeClinic in Hong Kong
HONG KONG, May 20, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s wholly owned Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce a c...
2021-05-20 12:00
9221
Idealmed GHS, part of European health group IGHS, commissions new Oman International Hospital in Muscat, Oman
MUSCAT, Oman, May 20, 2021 /PRNewswire/ -- The Idealmed Global Healthcare
Services (Idealmed GHS), part of the european health group IGHS, based in
Coimbra,Portugal, starts the comissioning of the impressive "Oman International
Hospital".
2021-05-20 12:00
2093
Alphamab Oncology to Present Multiple Clinical Research Data at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021)
SUZHOU, China, May 20, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced, data from three clinical studies of the PD-L1/CTLA-4 bispecific antibody KN046 will be presented in Poster session at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021) to be held...
2021-05-20 09:34
8748
ASCO 2021 | Ascentage Pharma to Announce Updated Data of Lisaftoclax (APG-2575) Demonstrating an ORR of Around 80% and Therapeutic Potential in Patients with R/R CLL/SLL in Oral Presentation
SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that an abstract reporting on...
2021-05-20 08:44
4632
ASCO 2021 | Ascentage Pharma to Announce Updated Results Demonstrating Clinical Potential of Alrizomadlin (APG-115) Plus Pembrolizumab in Patients with Advanced Solid Tumors that Had Failed Immunotherapies in Oral Presentation
SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that abstracts reporting on t...
2021-05-20 08:17
4993
Transcenta Announced the Results of the Phase I Clinical Study of PD-L1 Antibody MSB2311 with Advanced Solid Tumors and Hematological Malignancies
SUZHOU, China, May 20, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced that the updated Phase I clinical study (NCT04272944) d...
2021-05-20 08:00
2163
Medical Plastics' Remarkable Features Key to Hasten Growth of the Global Medical Plastics Market
Demand for materials that offer lightweighting, recyclability, and miniaturization is responsible for the adoption of plastics across various medical application areas, says Frost & Sullivan SANTA CLARA, Calif., May 20, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Transformative Mega...
2021-05-20 05:01
1642
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...
2021-05-18 21:00
1771
Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms
Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp's Chief Operating Officer TOKYO, May 18, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, phar...
2021-05-18 18:00
2789
Nanoform's final clinical results confirm value proposition to the pharma industry
HELSINKI, Finland, May 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. Th...
2021-05-18 13:48
1257
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, May 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX: 01801) and Eli Lilly and Company (NYSE: LLY) today jointly announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for sintilimab injection in...
2021-05-18 12:14
12335
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
2606
Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System
TAIPEI, May 18, 2021 /PRNewswire/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies inAsia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell cloning and quantifica...
2021-05-18 10:32
13261
Hummingbird Bioscience Raises US$125 Million in Series C Financing
* Investment round led by Novo Holdings, joined by a syndicate of international biotech investors * Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision therapeutics * Kenneth Harrison from Novo Ventures ...
2021-05-18 09:35
2516
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients
SINGAPORE, May 18, 2021 /PRNewswire/ -- Farrer Park Hospital
2021-05-18 08:15
1923
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community
The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...
2021-05-18 04:44
1433
ISMRM Awards Gold Medals At Annual Meeting And Announces New President
CONCORD, Calif., May 17, 2021 /PRNewswire/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) is holding its Annual Meeting this week and will recognize several achievements with prestigious awards. The Gold Medal award is the organization's highest honor and is awarded to r...
2021-05-17 23:00
2065
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
1884
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 273 media titles]
2024-11-29 20:33
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
13075
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9154
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8279
